Psychedelics, once heavily restricted for research, are now being rigorously tested through clinical trials to explore their potential therapeutic benefits. But how are women represented in the search to uncover the efficacy of psychedelic medicines? While the inclusion of women in psychedelic clinical trials is clearly important – both to understand the effects of these […]

The post Mind the Gap: The Importance of Gender Equity in Psychedelic Clinical Trials appeared first on Psychedelics Today.

Previous articleInside Synthesis Institute’s Implosion
Next articleSmall Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry